Skip to content

Clinical trials

Phase 2 Neuroinflammatory Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroinflammatory Diseases Phase: Phase 2 Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20112
20151
20161
20181
20191
20201
20213
20223
20233
20244
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting6
Unknown status4
Not yet recruiting3
Enrolling by invitation2
Terminated2
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ain Shams University2
Aaron Ritter, MD1
Bioxodes S.A.1
Boston University Charles River Campus1
Cambridge University Hospitals NHS Foundation Trust1
Centre Hospitalier St Anne1
Chang Gung Memorial Hospital1
Elixiron Immunotherapeutics Inc.1
Hasanuddin University1
Huntington Medical Research Institutes1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroinflammatory Diseases29
Alzheimer Disease6
Inflammation5
Brain Injuries, Traumatic3
Cognitive Dysfunction3
Multiple Sclerosis3
Parkinson Disease3
Cerebral Hemorrhage2
Schizophrenia2
Amyotrophic Lateral Sclerosis1

Trials

Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.